Related Experiment Video
Updated: Jun 28, 2025
07:18
Evaluation of Capillary and Other Vessel Contribution to Macular Perfusion Density Measured with Optical Coherence Tomography Angiography
Published on: February 18, 2022
1.8K
Correlation Between the Severity of Coronary Artery Disease and Retinal Artery Disease and the Therapeutic Effect of
Alternative Therapies in Health and Medicine
|April 12, 2024
Summary
Retinal artery disease severity correlates with coronary artery disease in hypertensive patients. Angiotensin-converting enzyme inhibitors like captopril may improve both conditions, but individualized treatment is key.
Area of Science:
- Cardiology
- Ophthalmology
- Pharmacology
Background:
- Hypertension is a significant risk factor for cardiovascular and cerebrovascular diseases.
- Coronary artery disease (CAD) and retinal artery disease (RAD) share common risk factors and pathophysiological mechanisms.
- Early detection of systemic vascular damage is crucial for managing hypertensive patients.
Purpose of the Study:
- To investigate the correlation between the severity of coronary artery disease (CAD) and retinal artery disease (RAD) in patients with primary hypertension.
- To assess the efficacy of Angiotensin-Converting Enzyme Inhibitors (ACEIs) in managing CAD and RAD.
- To explore the potential of retinal vessel assessment as an indirect indicator of coronary artery stenosis.
Main Methods:
- One hundred primary hypertension patients underwent dual-source CT coronary angiography and fundus photography.
- Patients were stratified into four groups based on the extent of coronary artery stenosis.
- Retinal artery stenosis and arteriovenous crossing signs were evaluated and correlated with CAD severity.
Main Results:
- A significant positive correlation was found between the severity of coronary artery lesions and retinal artery lesions (P < .05).
- Retinal artery stenosis and arteriovenous crossing signs increased with the severity of coronary artery stenosis.
- Treatment with captopril (an ACEI) led to significant reductions in systolic and diastolic blood pressure.
Conclusions:
- Retinal vascular changes serve as an indirect indicator of coronary artery stenosis in hypertensive individuals.
- ACEIs, specifically captopril, show potential in alleviating both coronary and retinal artery lesions.
- Treatment strategies for hypertensive patients should be individualized based on their specific condition.
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
627
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
627
01:14Time Course of Drug Effect
2.0K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.0K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
720
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
720
01:25Antihypertensive Drugs: Direct Renin Inhibitors
613
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
613
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
160
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
160